“Examining the Therapeutic Potential of CRISPR-Cas9 Gene Editing in Spondyloarthritis: Efficacy of TNF Inhibitor Adalimumab: Research Article” (2024) International Journal of Research in Medical and Clinical Science, 2(02), pp. 20–30. doi:10.70829/ijrmcs.v2.i2.0724002.